Articles

10.4244/EIJV9I4A77 Aug 23, 2013
Implementation of a physician-staffed helicopter: impact on time to primary PCI
Hesselfeldt R, Pedersen F, Steinmetz J, Vestergaard L, Simonsen L, Jørgensen E, Clemmensen P, Rasmussen L
free

10.4244/EIJV9I4A78 Aug 23, 2013
Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry
Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe U, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump L, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G
free

10.4244/EIJV9I4A80 Aug 23, 2013
Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)
Kajiya T, Liang M, Sharma R, Lee C-H, Chan M, Tay E, Chan K-H, Tan H-C, Low A
free

10.4244/EIJV9I4A81 Aug 23, 2013
First-in-man intracoronary use of the Trevo® Pro 4 mechanical thrombectomy device for the retrieval of large intracoronary thrombus in patients with acute coronary syndromes
van de Hoef TP, Woudstra P, Sprengers M, Koch K, Majoie C, Piek J, de Winter R
free

10.4244/EIJV9I3A48 Jul 26, 2013
The Journal Citation Reports® Impact Factor: annual results 2012
Cummins P, Serruys PW
free

10.4244/EIJV9I3A52 Jul 26, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco DJ, Dawkins K
free

10.4244/EIJV9I3A54 Jul 26, 2013
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial
Jiménez-Quevedo P, Hernando L, Gomez-Hospital J, Iñiguez A, San Román A, Alfonso F, Hernández-Antolín R, Angiolillo D, Banuelos C, Escaned J, Gonzalo N, Fernandez C, Macaya C, Sabaté M
free

10.4244/EIJV9I3A55 Jul 26, 2013
Long-term comparison of everolimus-eluting and biolimus-eluting stents
Puricel S, Oberhänsli M, Guntern P, Lehmann S, Goy J-J, Arroyo D, Villeneuve H, Baeriswyl G, Stauffer J-C, Togni M, Cook S
free

10.4244/EIJV9I3A57 Jul 26, 2013
Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy
Niccoli G, Stuteville M, Sudhir K, Li D, Montone R, Bolognese L, Grube E
free

10.4244/EIJV9I3A58 Jul 26, 2013
The impact of gender on fractional flow reserve measurements
Fineschi M, Guerrieri G, Orphal D, Palmerini E, Munzel T, Warnholtz A, Pierli C, Gori T
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved